Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Ascletis Lands $1.6 Million R&D Grant from Hangzhou Park

publication date: Jan 4, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Ascletis, a US-China joint venture pharmaceutical company, received a 10 million RMB ($1.6 million) R&D grant from the Hangzhou National Hi-Tech Industrial Development Zone (HHTZ), the site of its China operations. According to Ascletis, the award is the largest grant ever made to a startup company from the HHTZ "5050 Plan.” Financial backing seems to come naturally to Ascletis. In April of 2011, Ascletis was launched with an initial funding of $100 million. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners